Can pro-oxidants fight prostate cancer? Lloyd Trotman, PhD @CSHL joins @AndreaMiyahira @PCFnews to discuss how a surprising twist from the #SELECT trial led to "triaptosis"—a new cell death mechanism triggered by menadione (vitamin K precursor). Promising results in mouse models
